SCHEMBL8181781

SCHEMBL8181781

O=C1NC(=O)C(CCOCc2ccccc2)O1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.46
ALDH1A1 P00352 2/20 0.42
CA2 P00918 1/20 0.41
CYP4F2 P78329 1/20 0.41
CYP4A11 Q02928 1/20 0.41
TSHR P16473 1/20 0.40
NAAA Q02083 1/20 0.38
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37
HRH4 Q9H3N8 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
PDE4D Q08499 1/20 0.36
PPARG P37231 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
AKT1 P31749 1/20 0.35
CCKBR P32239 1/20 0.35
CDC7 O00311 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8889741 0.77 FFAR1 (0.48) BCHE
SCHEMBL8888011 0.74 LTA4H (0.49) CYP4F2CYP4A11BCHE
SCHEMBL5836429 0.74 ALDH1A1 (0.48) LMNAALDH1A1TSHRBCHEACHE
SCHEMBL7987732 0.73 MEN1 (0.49) LMNABCHEPPARGMEN1KMT2A
SCHEMBL8888854 0.73 MGLL (0.50) CYP4F2CYP4A11BCHE
SCHEMBL8890354 0.73 MGLL (0.50) CYP4F2CYP4A11BCHE
SCHEMBL8888505 0.73 MGLL (0.50) CYP4F2CYP4A11BCHE
SCHEMBL15239316 0.71 TAAR1 (0.41) LMNAALDH1A1TSHRNAAATAAR1
SCHEMBL1459291 0.71 LMNA (0.49) LMNAALDH1A1TSHRNAAATAAR1
SCHEMBL1459289 0.71 LMNA (0.49) LMNAALDH1A1TSHRNAAATAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000018745-A1 OXAZOLIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF METABOLIC BONE DISORDERS ROCHE DIAGNOSTICS GMBH (DE) 2000-04-06 WO disclosed